Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Fotemustine vs Surveillance in High Risk Uveal Melanoma
NCT02843386Phase 3Completed
- Sponsor
- Institut Curie
- Start
- Jun 2009
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of fotemustine in Uveal melanoma (UM), sponsored by Institut Curie. Started Jun 2009; status: completed.
02
Drugs
fotemustine
03
Conditions
Uveal melanoma (UM)
Beyond the preview
Go deeper on NCT02843386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02843386.